Multiple Sclerosis?The Unexpected Effect of a Popular Longevity Therapy #longevity #health #medicine

A new study published in the journal PNAS has called into question the safety of one of the most popular anti-aging therapies—the combination of dasatinib and quercetin (D+Q). Scientists have discovered that senolytic therapy, designed to remove senescent cells, can cause changes in the brain reminiscent of those seen in multiple sclerosis. What are senolytics? Why is removing "senescent" cells considered a promising area of ​​longevity medicine? And why has interfering with the mechanisms of aging proven much more difficult than expected? In this video, we explore: - How senolytics work - What the researchers discovered - Why myelin was damaged - What happened to oligodendrocytes - How dangerous is this for people - And is it worth experimenting with such regimens after 50? Contents: 00:00 Can a popular anti-aging drug harm the brain? 00:08 What are senolytics and how does D+Q work? 01:52 How D+Q affects a healthy brain. 02:12 Why scientists are interested in multiple sclerosis. 03:03 Mouse experiment: unexpected results. 03:26 What happened to myelin and brain cells. 04:45 What caused these changes. 06:18 Should we be wary of senolytics after 50? Scientific sources: https://pubmed.ncbi.nlm.nih.gov/41843680/ https://www.pnas.org/doi/10.1073/pnas.2524897123?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed #longevity, #aging, #senolytics, #brain, #multiplesclerosis, #health, #neuroscience, #antiaging, #biohacking, #science, #medicine, #after50, #rejuvenation, #quercetin, #dasatinib ⚠️ The information in the video is for informational purposes only and is not medical advice. Before using any medications, supplements, or changes in treatment, consult your doctor.